Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis

被引:6
作者
Frei, P. [1 ]
Weber, A. [2 ]
Geier, A. [1 ]
Mertens, J. C. [1 ]
Kohler, S. [1 ]
Rogler, G. [1 ]
Muellhaupt, B. [1 ]
机构
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Pathol, Inst Surg Pathol, CH-8091 Zurich, Switzerland
关键词
diarrhea; Cryptosporidium diarrhea; mycophenolate mofetil; drug toxicity; infection; LIVER-TRANSPLANTATION; BIOPSIES;
D O I
10.1111/j.1399-3062.2011.00653.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Diarrhea in a transplant recipient may be caused by infection, metabolic problems, or adverse drug effects. The immunosuppressive drug most frequently associated with diarrhea in transplant recipients is mycophenolate mofetil (MMF). We present the case of a patient with 2 potential explanations for diarrhea lasting several weeks, which occurred years after liver transplantation. Whereas stool samples were positive for cryptosporidia, the histopathological findings were compatible with MMF colitis. However, diarrhea resolved after treatment of cryptosporidial infection, despite continued MMF medication. This case shows that histopathological findings of MMF colitis may be misleading and do not prove that diarrhea is drug induced.
引用
收藏
页码:416 / 418
页数:3
相关论文
共 17 条
[1]  
BLANSHARD C, 1992, Q J MED, V85, P813
[2]   Minireview: Clinical cryptosporidiosis [J].
Chalmers, Rachel M. ;
Davies, Angharad P. .
EXPERIMENTAL PARASITOLOGY, 2010, 124 (01) :138-146
[3]   Cryptosporidium parvum-associated sclerosing cholangitis in a liver transplant patient [J].
Denkinger, C. M. ;
Harigopal, P. ;
Ruiz, P. ;
Dowdy, L. M. .
TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (02) :133-136
[4]   Cryptosporidiosis after liver transplantation [J].
Dumortier, J ;
Cruchaudet, B ;
Piens, MA ;
Bouffard, Y ;
Peyregne, V ;
Boillot, O .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (11) :1186-1187
[5]  
Groth CG, 1996, TRANSPL P, V28, P30
[6]   Gastrointestinal complications in liver transplant recipients:: MITOS study [J].
Herrero, J. I. ;
Benlloch, S. ;
Bernardos, A. ;
Bilbao, I. ;
Castells, L. ;
Castroagudin, J. F. ;
Gonzalez, L. ;
Irastorza, I. ;
Navasa, M. ;
Otero, A. ;
Pons, J. A. ;
Rimola, A. ;
Suarez, F. ;
Casanovas, T. ;
Otero, E. ;
Rodriguez, M. ;
Serrano, T. ;
Otero, S. ;
Lopez, I. ;
Miras, M. ;
Prieto, M. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2311-2313
[7]   Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients [J].
Hunter, PR ;
Nichols, G .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (01) :145-+
[8]  
Letavernier Emmanuel, 2008, Transplant Rev (Orlando), V22, P125, DOI 10.1016/j.trre.2007.12.001
[9]   Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation [J].
Manz, M. ;
Steuerwald, M. .
TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) :60-61
[10]  
Orenstein JM, 2001, ARCH PATHOL LAB MED, V125, P1042